Literature DB >> 9427873

The association between premenstrual dysphoric disorder and other mood disorders.

K A Yonkers1.   

Abstract

Premenstrual dysphoric disorder (PMDD) is a premenstrual mood disorder that cyclically recurs during the majority of menstrual cycles. It is included under the category of "depressive disorders not otherwise specified" in DSM-IV. Given the placement of PMDD with other mood disorders in DSM-IV, the evidence suggesting an association between PMDD and other mood disorders is examined. Primary reports on the epidemiology, phenomenology, family history, psychobiology, and treatment of PMDD were examined for features that are commonly found in other mood disorders. There is an overlap in the symptoms experienced by women with PMDD and patients with other mood disorders. As in patients with other mood disorders, past episodes of mood disorder and family history of mood disorder are common in women with PMDD. Selected biological markers differentiate women with PMDD from controls, and some but not all antidepressants are effective in the treatment of PMDD. Many features of PMDD support its inclusion in the DSM-IV category of mood disorders. However, a number of factors (biological and cognitive studies, treatment response) differentiate PMDD from other mood disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427873

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  14 in total

1.  Lifetime discrimination associated with greater likelihood of premenstrual dysphoric disorder.

Authors:  Corey E Pilver; Rani Desai; Stanislav Kasl; Becca R Levy
Journal:  J Womens Health (Larchmt)       Date:  2011-06       Impact factor: 2.681

Review 2.  Menstrual cycle-related exacerbation of disease.

Authors:  Joann V Pinkerton; Christine J Guico-Pabia; Hugh S Taylor
Journal:  Am J Obstet Gynecol       Date:  2010-03       Impact factor: 8.661

Review 3.  Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics.

Authors:  Marie K Osterlund; Michael-Robin Witt; Jan-Ake Gustafsson
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

4.  Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences.

Authors:  Rebecca R Klatzkin; Monica E Lindgren; Catherine A Forneris; Susan S Girdler
Journal:  Biol Psychol       Date:  2010-02-04       Impact factor: 3.251

Review 5.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 6.  Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.

Authors:  Andrea J Rapkin; Judith A Mikacich
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

7.  Menstrual mood disorders are associated with blunted sympathetic reactivity to stress.

Authors:  Rebecca R Klatzkin; Adomas Bunevicius; Catherine A Forneris; Susan Girdler
Journal:  J Psychosom Res       Date:  2013-11-12       Impact factor: 3.006

8.  Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey.

Authors:  George M Anderson; Christina S Barr; Stephen Lindell; Amy C Durham; Ilya Shifrovich; J Dee Higley
Journal:  Psychopharmacology (Berl)       Date:  2004-09-25       Impact factor: 4.530

Review 9.  A reproductive subtype of depression: conceptualizing models and moving toward etiology.

Authors:  Jennifer L Payne; Jennifer Teitelbaum Palmer; Hadine Joffe
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

10.  Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause.

Authors:  Ellen W Freeman
Journal:  Dialogues Clin Neurosci       Date:  2002-06       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.